- Trials with a EudraCT protocol (20)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
20 result(s) found for: Anal fistula.
Displaying page 1 of 1.
EudraCT Number: 2009-014775-42 | Sponsor Protocol Number: CX-401-0304 | Start Date*: 2009-12-28 | |||||||||||
Sponsor Name:CELLERIX S.A. | |||||||||||||
Full Title: Estudio prospectivo para la evaluación de la seguridad y eficacia a largo plazo de Cx401 en pacientes que hayan participado en el ensayo clínico FATT2. A prospective study for the assessment of th... | |||||||||||||
Medical condition: Fistula perianal compleja en la enfermedad perianal de Crohn Complex perianal fistula in perianal Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003140-10 | Sponsor Protocol Number: CX401-0303 | Start Date*: 2008-10-03 | |||||||||||
Sponsor Name:Cellerix, S.A. | |||||||||||||
Full Title: Estudio prospectivo para la evaluación de la seguridad y eficacia a largo plazo de CX401 en pacientes que han participado en el ensayo FATT-1 | |||||||||||||
Medical condition: Fistula perianal compleja | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007445-31 | Sponsor Protocol Number: Cx601-0101 | Start Date*: 2009-03-26 | |||||||||||
Sponsor Name:Cellerix, S.A | |||||||||||||
Full Title: Estudio multicéntrico fase I-IIa para evaluar la seguridad y eficacia de células madre expandidas derivadas de tejido adiposo alogénico (eASCs) (Cx601) para el tratamiento de las fístulas perianale... | |||||||||||||
Medical condition: Tratamiento de las fístulas perianales complejas en la enfermedad perianal de Crohn. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004286-25 | Sponsor Protocol Number: CX-401/FATT2 | Start Date*: 2008-12-04 | |||||||||||
Sponsor Name:CELLERIX S.A. | |||||||||||||
Full Title: Estudio fase III, multicéntrico, simple ciego, randomizado, controlado con placebo, para evaluar la eficacia y seguridad de células madre expandidas derivadas de tejido adiposo autólogo (eASCs) (CX... | |||||||||||||
Medical condition: Fístula perianal compleja en pacientes con enfermedad de Crohn. Complex perianal fistula in perianal Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) NL (Completed) AT (Prematurely Ended) DE (Prematurely Ended) BE (Completed) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003370-95 | Sponsor Protocol Number: Cx401/FATT1 | Start Date*: 2008-02-06 | |||||||||||
Sponsor Name:CELLERIX, S.L. | |||||||||||||
Full Title: "A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologou... | |||||||||||||
Medical condition: Treatment of complex perianal fistulas in patients without inflammatory bowel disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003197-23 | Sponsor Protocol Number: PB_A&A-ASC-FISTULA_1.0 | Start Date*: 2024-12-20 | |||||||||||
Sponsor Name:Jagiellonian University - Medical College | |||||||||||||
Full Title: Multicenter, controlled, randomized clinical trial comparing the efficacy of auto- and allogeneic mesenchymal stromal cells in the healing of Crohn-related anal fistulas | |||||||||||||
Medical condition: Anal or recto-cutaneous or recto-vaginal Crohn-related fistula | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006127-38 | Sponsor Protocol Number: PRGF/AF/SIN/2011 | Start Date*: 2012-06-05 | ||||||||||||||||
Sponsor Name:Fundación FISEVI | ||||||||||||||||||
Full Title: Phase II, open-label clinical trial to evaluate the safety and efficacy of platelet-rich plasma and fibrin clot in processed with PRGF-system technology, in the treatment of anal fistulas in Crohn'... | ||||||||||||||||||
Medical condition: Perianal fistulas in Crohn's Disease Patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000333-39 | Sponsor Protocol Number: Darvadstrocel-3003 | Start Date*: 2019-10-15 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc | |||||||||||||
Full Title: A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn’s Disease Who Have Participated in ... | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) FR (Completed) HU (Completed) ES (Completed) BE (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002491-10 | Sponsor Protocol Number: Alofisel-4001 | Start Date*: 2020-03-10 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: Postauthorization Safety Study of the Long-Term Safety and Efficacy of Repeat Administration of Darvadstrocel in Patients With Crohn’s Disease and Complex Perianal Fistula | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Trial now transitioned) ES (Trial now transitioned) DE (Trial now transitioned) FR (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006064-43 | Sponsor Protocol Number: Cx601-0302 | Start Date*: 2012-09-27 | |||||||||||
Sponsor Name:TiGenix S.A.U. | |||||||||||||
Full Title: A phase III, randomised, double blind, parallel group, placebo controlled, multicentre study to assess efficacy and safety of expanded allogeneic adipose-derived stem cells (eASCs) for the treatm... | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) ES (Completed) IT (Completed) AT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001002-18 | Sponsor Protocol Number: HUGTP-CIR-OFF | Start Date*: 2021-05-04 |
Sponsor Name:Hospital Universitari Germans Trias i Pujol | ||
Full Title: Pathophysiological mechanisms in the development of anal fistula. Oral antibiotics after anal abscess drainage to diminish perianal Fistula Formation: a multicenter, randomized, observer-blind, pla... | ||
Medical condition: Abscess and anal fistulas | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003376-14 | Sponsor Protocol Number: 1 | Start Date*: 2021-11-26 |
Sponsor Name:Mariano Artes Caselles | ||
Full Title: Efficacy of amoxicillin/clavulanic acid after surgical drainage of perianal abscess in the prevention of the development of anal fistula. A randomized, double-blind clinical trial. | ||
Medical condition: perianal abscess | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002579-16 | Sponsor Protocol Number: FFF/2013 | Start Date*: 2014-12-09 |
Sponsor Name:C. HOSPITALARIO VIRGEN DEL ROCIO | ||
Full Title: PHASE III CLINICAL TRIAL, single-center, randomized, double blind IN TWO GROUPS PARALLELS TO COMPARE THE EFFICACY AND SAFETY OF RICH PLASMA GROWTH FACTORS (PRGF) IN FRONT OF fibrin glue (TISSUCOL ... | ||
Medical condition: Anal and criptoglandular fistula | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001209-34 | Sponsor Protocol Number: PRGFFC17 | Start Date*: 2018-05-28 |
Sponsor Name:FISEVI | ||
Full Title: Phase III CLINICAL TRIAL, MULCHNTRIC, RANDOMIZED, BLIND DOUBLE IN TWO PARALLEL GROUPS TO COMPARE THE EFFECTIVENESS AND SAFETY OF THE SIMPLE CLOSURE OF THE CRYPTTOGLANDULAR ANAL FISTULA WITH OR WITH... | ||
Medical condition: Patients with anal fistula | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004820-37 | Sponsor Protocol Number: PRGF/AF/2011 | Start Date*: 2012-06-13 | ||||||||||||||||
Sponsor Name:Fundación FISEVI | ||||||||||||||||||
Full Title: Phase II, open-label clinical trial to evaluate the safety and efficacy of platelet-rich plasma and fibrin clot processed with PRGF-System tecnology in the treatment of anal fistulas in Crohn's pat... | ||||||||||||||||||
Medical condition: Perianal fistulas in Crohn's Disease Patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004449-35 | Sponsor Protocol Number: 80-86600-98-19047 | Start Date*: 2021-05-06 |
Sponsor Name:ZonMw | ||
Full Title: Antibiotic treatment following surgical drainage of perianal abscess: a double-blind, placebo-controlled, randomized trial | ||
Medical condition: Perianal fistula | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002811-33 | Sponsor Protocol Number: LAINCO1107 | Start Date*: 2017-12-11 | |||||||||||
Sponsor Name:LAINCO S.A | |||||||||||||
Full Title: Unilateral, open and randomized phase IV study of 2 groups to assess the degree of comfort with simple Emuliquen® in patients undergoing proctological surgery | |||||||||||||
Medical condition: Surgery proctological | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015680-14 | Sponsor Protocol Number: allo bmMSCs CD fistula | Start Date*: 2010-05-18 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients with Refractory Perianal Crohn’s Disease | |||||||||||||
Medical condition: single or multiple draining perianal fistulas as a result of Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002311-41 | Sponsor Protocol Number: 2014-3 | Start Date*: 2014-08-12 |
Sponsor Name:GETAID | ||
Full Title: A proSpective randomized controlled trial comParing infliximAb-antimetabolites combination therapy to anti-metabolites monotheRapy and infliximab monothErapy in Crohn’s disease patients in sustaine... | ||
Medical condition: Luminal Crohn’s disease patients with steroid free remission for at least 6 months and a combination therapy with infliximab and anti-metabolites for at least 1 year | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) GB (GB - no longer in EU/EEA) SE (Ongoing) DE (Completed) NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001295-65 | Sponsor Protocol Number: TXC-CD-002-2011 | Start Date*: 2014-11-28 | |||||||||||
Sponsor Name:TxCell | |||||||||||||
Full Title: A phase IIb, multicentre, randomised, double-blinded (DB), placebo-controlled, single-dose and parallel-group study to evaluate the efficacy and the safety of Ovasave (ovalbumin-specific autologous... | |||||||||||||
Medical condition: Moderately to severely active Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) AT (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
